Targeting PERK to treat arrhythmias

Trends Mol Med. 2023 Aug;29(8):583. doi: 10.1016/j.molmed.2023.05.005. Epub 2023 Jun 3.

Authors

Man Liu¹, Gyeoung-Jin Kang¹, Samuel C Dudley Jr²

Affiliations

¹ Division of Cardiology, Department of Medicine, the Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA.
² Division of Cardiology, Department of Medicine, the Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA. Electronic address: sdudley@umn.edu.

PMID: 37277278
DOI: 10.1016/j.molmed.2023.05.005

No abstract available

Keywords: antiarrhythmic therapy; arrhythmia; cardiomyopathy; unfolded protein response.

Publication types

Letter

MeSH terms

Anti-Arrhythmia Agents* / therapeutic use
Arrhythmias, Cardiac* / drug therapy
Humans

Substances

Anti-Arrhythmia Agents

Grants and funding

R56 HL162208/HL/NHLBI NIH HHS/United States